Free Trial

Ascend Wellness (OTC:AAWH) Stock Price Down 0.6%

Ascend Wellness logo with Medical background

Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) dropped 0.6% during trading on Thursday . The company traded as low as $0.85 and last traded at $0.89. Approximately 167,151 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 218,549 shares. The stock had previously closed at $0.89.

Wall Street Analyst Weigh In

Separately, Ventum Cap Mkts raised shares of Ascend Wellness to a "strong-buy" rating in a research report on Tuesday, July 16th.

Read Our Latest Report on Ascend Wellness

Ascend Wellness Price Performance

The company has a debt-to-equity ratio of 2.46, a current ratio of 2.29 and a quick ratio of 1.29. The company has a market capitalization of $188.27 million, a PE ratio of -3.85 and a beta of 1.72. The stock's 50 day simple moving average is $0.99 and its 200-day simple moving average is $1.08.

Ascend Wellness (OTC:AAWH - Get Free Report) last released its earnings results on Monday, August 5th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.03). Ascend Wellness had a negative return on equity of 50.77% and a negative net margin of 12.48%. The firm had revenue of $141.54 million for the quarter, compared to analysts' expectations of $145.48 million. As a group, equities analysts forecast that Ascend Wellness Holdings, Inc. will post -0.32 earnings per share for the current fiscal year.

About Ascend Wellness

(Get Free Report)

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.

Further Reading

→ Don’t wait for FDA approval (From Weiss Ratings) (Ad)

Should you invest $1,000 in Ascend Wellness right now?

Before you consider Ascend Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.

While Ascend Wellness currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Congress Is Betting Big on Broadcom in 2024
What the Bulls and Bears Are Saying About NVIDIA Stock
Nvidia Tops Congressional Buy List

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines